2013 Musculoskeletal New Ventures Conference This Week

Investors and entrepreneurs from around the world will be in Memphis October 22 and 23, 2013, to attend the Eleventh Annual Musculoskeletal New Ventures Conference, which is taking place at the FedEx Institute of Technology at the University of Memphis.  Surgeons, venture capitalists, industry leaders, and researchers gather for this one-of-a-kind opportunity to share information in the fast growing, dynamic and revolutionary field of musculoskeletal research and commercialization.

The Musculoskeletal New Ventures Conference exposes venture capitalists (VCs) to new ideas, new companies and new opportunities.  For 11 years, this conference has promoted dialog and built relationships between funding resources and entrepreneurs, while enabling emerging musculoskeletal companies to promote their ideas to business leaders worldwide.  This year’s event is expected to be attended by dozens of VCs, representing millions of dollars in venture capital under management.  They will hear from more than 20 diverse start-up companies that are developing new and emerging therapies for orthopedics and spine.

The 11th Annual Musculoskeletal New Ventures Conference is hosted by MB Venture Partners and Memphis Bioworks Foundation.  For more information on the conference or to register, visit www.mnvc.org. The De Angelis Group, a Retained Executive Search firm specializing in the orthopedic, spine and biologics industries is sponsoring the Musculoskeletal New Ventures Conference for the sixth year running. Drue DeAngelis, speaking about the event, “we have been honored to be a sponsor and play a very small part in what this meeting contributes to the orthopedic start up space. It is gratifying to see so many of our clients reaching new milestones and overcoming challenges. This year, we will again be raffling off two day passes to the final round of The Masters Golf Tournament in Augusta, GA”

About MB Venture Partners

MB Venture Partners is a Memphis-based venture capital firm that provides equity capital and strategic direction to life sciences start-ups. The Firm invests in medical device and biotechnology companies at various stages of development and has now funded 24 start-ups. The Firm is especially focused on product solutions for musculoskeletal conditions, where we have specific domain expertise and relationships to assist portfolio companies. For more information, visit www.mbventures.com.


About the Memphis Bioworks Foundation

The Memphis Bioworks Foundation, a not-for-profit organization, was formed to lead the collaboration among public, private, academic, and government entities to accelerate the growth of the bioscience industry in the region. Memphis Bioworks strives to leverage and expand the regional strengths in the biosciences through education, research, job training, and commercialization. Memphis Bioworks is leading the development of the UT-Baptist Research Park, which serves as the focal point of the city’s biomedical economic development. For more information, visit www.memphisbioworks.org.


Josh Sandberg

Josh Sandberg is the President of Ortho Sales Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *